Showing
1 - 5
results of
5
for search '
Strauss, James
'
Skip to content
ifa
Discovery
de
Menu
Home
Login
Feedback
0
items in your basket
(Full)
ifa / FIV / JSTOR
Find
Advanced Search
Thematic search
Author
Strauss, James
Showing
1 - 5
results of
5
for search '
Strauss, James
'
, query time: 0.18s
Refine Results
Results per page
10
20
40
60
80
100
Sort
Relevance
Date Descending
Date Ascending
Call Number
Author
Title
1
The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis
by:
Fine, Robert L.
Published in:
Cancer chemotherapy and pharmacology
(2007)
Other Authors:
“
...
Strauss
,
James
...
”
lizenzpflichtig
electronic Article
Add to Basket
Remove from Basket
2
The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis
by:
Fine, Robert L.
Published in:
Cancer chemotherapy and pharmacology
(2007)
Other Authors:
“
...
Strauss
,
James
...
”
lizenzpflichtig
electronic Article
Add to Basket
Remove from Basket
3
QTL influencing baseline hematocrit in the C57BL/6J and DBA/2J lineage: age-related effects
by:
Johannes, Frank
Published in:
Mammalian genome
(2006)
Other Authors:
“
...
Strauss
,
James
A....
”
lizenzpflichtig
electronic Article
Add to Basket
Remove from Basket
4
Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors
by:
Någård, Mats
Published in:
Cancer chemotherapy and pharmacology
(2023)
Other Authors:
“
...
Strauss
,
James
...
”
kostenfrei
electronic Article
Add to Basket
Remove from Basket
5
Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study
by:
Någård, Mats
Published in:
Cancer chemotherapy and pharmacology
(2023)
Other Authors:
“
...
Strauss
,
James
...
”
kostenfrei
electronic Article
Add to Basket
Remove from Basket
Search Tools:
Get RSS Feed
—
Email this Search
Related Subjects
AZD1775
Adavosertib
Pharmacokinetics
CYP1A2
CYP2C19
CYP3A
Capecitabine
Docetaxel
Erlotinib
Gemcitabine
Pancreatic Cancer
Pharmacodynamics
QT interval
Quantitative Trait Locus
Recombinant Inbred
Significant Quantitative Trait Locus
Single Nucleotide Polymorphism Effect
Single Nucleotide Polymorphism Marker
Wee1 inhibitor
Covers © buchhandel.de
Loading...